๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve
NCT07347340Diminished Ovarian Reserve (DOR)
Peking Union Medical College Hospital
Phase 3
348
Beijing
2026-01-01
Not yet open
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950Acute Basilar Artery Occlusion, Endovascular Therapy, Large Core Infarction
Beijing Tiantan Hospital
Not applicable
308
Beijing
2026-01-01
Recruiting
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711Chronic Hepaititis B
Peking University People's Hospital
Phase EARLY_PHASE1
132
Beijing
2026-01-01
Not yet open
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication
Peking University People's Hospital
Observational
4,000
Beijing, Chongqing, Hangzhou, Harbin, Tianjin, Wuhan
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Recruiting
Ablation Compare With Surgery for Early Breast Cancer
NCT07484087Breast Cancer, Early Stage, Hormone Receptor Positive, Ablation
Peking University People's Hospital
Not applicable
264
Beijing
2026-01-01
Recruiting
Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
NCT06946654Elderly, Geriatric Assessment, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital
Observational
176
Beijing
2026-01-01
Recruiting
Raman Spectroscopy-Based Non-Invasive Blood Glucose Detection
NCT07311421Diabetes
Beijing Shijitan Hospital, Capital Medical University
Observational
49
Beijing, Haidian
2026-01-01
Not yet open
Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT07381582Prostate Cancer
Peking Union Medical College Hospital
Phase EARLY_PHASE1
15
Beijing, Mianyang
2026-01-01
Recruiting
Golidocitinib Combined With Selinexor for CAEBVD
NCT07369739Lymphohistiocytosis, EBV, CAEBV
Beijing Friendship Hospital
Phase 2/3
28
Beijing
2026-01-01
Not yet open
Comprehensive Care of Sleep Disordered Breathing
NCT07339371Sleep Disordered Breathing (SDB)
Beijing Anzhen Hospital
Observational
11,100
Beijing
2026-01-01
Active, closed
Treatment Outcomes for Osteochondritis Dissecans of the Knee: A Cohort Study
NCT07439107Osteochondritis Dissecans Knee, Osteochondritis Dissecans (OCD)
Peking University Third Hospital
Observational
254
Beijing
2026-01-01
Recruiting
Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY
NCT07137936Sudden Death, Cardiac, Myocardial Scarring, Myocardial Infarction (MI)
Beijing Anzhen Hospital
Observational
1,000
Beijing
2026-01-01
Active, closed
Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma
NCT07480837B-Cell Non-Hodgkin Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
60
Beijing
2026-01-01
Recruiting
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
NCT07367724Obstructive Hypertrophic Cardiomyopathy (oHCM)
China National Center for Cardiovascular Diseases
Phase 2
44
Beijing, Shanghai, Xinjiang
2026-01-01
Active, closed
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
NCT07597369Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Cancer (mCRPC)
Peking University First Hospital
Observational
1,600
Beijing
2026-01-01
Recruiting
Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.
NCT06946602AML, Elderly
Peking University People's Hospital
Not applicable
307
Beijing
2026-01-01
Recruiting
Clinical Validation of a Pre-trained and Fine-tuned Model for Analyzing Time-Series Electronic Health Records in Critical Care
NCT07795450Critical Care Medicine, Mortality Prediction
Peking University People's Hospital
Observational
4,800
Beijing
2026-01-01
Recruiting
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
NCT07438847Thyroid Cancer
SHAOYAN LIU
Phase 1
12
Beijing
2026-01-01
Active, closed
Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma
NCT07480850Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2026-01-01
Active, closed
The Clinical Application Value of "Showering Cells" in the Diagnosis of Aspiration Pneumonia
NCT07395310Pneumonia, Aspiration
Chinese PLA General Hospital
Observational
94
Beijing
2026-01-01
Recruiting
Metabolomics and Biomarker Research on the Mechanism of Preoperative Sleep Disorders Affecting Postoperative Outcomes in Cardiac Surgery Patients
NCT07588178Delirium - Postoperative, Sleep Problems
Yan Fuxia
Observational
144
Beijing
2026-01-01
Recruiting
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
NCT07303803MASH - Metabolic Dysfunction-Associated Steatohepatitis, T2DM (Type 2 Diabetes Mellitus)
Shanghai Jiao Tong University School of Medicine
Phase 2
300
Beijing, Chongqing, Fuzhou, Guangzhou, Wuhan, Shiyan, Changsha, Changchun
2026-01-01
Not yet open
Cough Flow as a Criterion Decannulation Threshold in Prolonged Tracheostomy Patients
NCT07317791Tracheostomy
Hongying Jiang, MD
Not applicable
500
Beijing, Hunan, Guangxi, Jilin City, Henan
2026-01-01
Recruiting
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT07315750Gastric Carcinoma
RemeGen Co., Ltd.
Phase 3
555
Beijing
2026-01-01
Not yet open
Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly
NCT07357714Chronic Kidney Disease, Overactive Bladder, Benign Prostatic Hyperplasia, Female Pelvic Floor Dysfunction
Chinese PLA General Hospital
Observational
500
Beijing
2026-01-01
By invitation
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease
NCT07372781Monotherapy, Mycobacterium Abscessus Infection
Beijing Chest Hospital
Phase 2
24
Beijing
2026-01-01
By invitation
Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
NCT07373899Carcinoma, Non-Small-Cell Lung, Neoadjuvant Immunotherapy, Surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
354
Beijing
2026-01-01
Not yet open
Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification
NCT07199101Radiation Dose Reduction
Beijing Children's Hospital
Not applicable
2,650
Beijing, Chongqing, Guangzhou, Baoding, Zhengzhou, Wuxi, Changchun, Xi'an
2026-01-01
Recruiting
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal Tuberculosis
NCT07575061Intestinal Tuberculosis
Beijing Chest Hospital, Capital Medical University
Observational
500
Beijing
2026-01-01
Not yet open
Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)
NCT07353762Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Beijing Anzhen Hospital
Observational
10,960
Beijing
2026-01-01
Recruiting
A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia
NCT07583706BPH (Benign Prostatic Hyperplasia)
Qing Yuan
Not applicable
5
Beijing
2026-01-01
Active, closed
Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery
NCT07446036Headache, Pituitary Adenoma, Endonasal Surgery, Predictive Model
Beijing Tiantan Hospital
Observational
500
Beijing
2026-01-01
By invitation
Immune Evaluation for Postoperative Sepsis-AKI
NCT07811544Sepsis, Acute Kidney Injury
Beijing Chao Yang Hospital
Observational
800
Beijing
2026-01-01
Recruiting
Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL
NCT07575919B-cell Acute Lymphoblastic Leukemia
Liping Dou
Phase 1/2
20
Beijing
2026-01-01
Not yet open
Multimodal Exercise Therapy for Non-Surgical Intervention of Nonspecific Low Back Pain.
NCT07353372Paraspinal Muscles, Low Back Pain, Machine Learning, Radiomics
Xuanwu Hospital, Beijing
Not applicable
314
Beijing
2026-01-01
Not yet open
AI Wound Alert & Home Management for Recurrent DFU
NCT07277010Diabetic Foot Ulcer (DFU)
Peking University Third Hospital
Observational
200
Beijing
2026-01-01
Not yet open
Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
NCT07279987Vascular Calcification
Lin Zhao
Not applicable
162
Beijing
2026-01-01
Recruiting
A Study of DC6001 Tablet in Healthy Chinese Adult Subjects
NCT07417566Stargardt Disease
Heronova Pharmaceuticals
Phase 1
76
Beijing
2026-01-01
Recruiting
Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia
NCT07575971B-cell Acute Lymphoblastic Leukemia
Liping Dou
Phase 1/2
30
Beijing
2026-01-01
Recruiting
CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma
NCT07587840Lymphoma
Liping Dou
Phase 2
20
Beijing
2026-01-01
Not yet open
Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019
NCT07282197Prostate Cancer
Peking University First Hospital
Phase 2
40
Beijing
2026-01
Not yet open
KN5501 Cell Injection for Refractory SLE(CLEAR)
NCT07358988Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD
Phase 1
36
Bengbu, Beijing, Luoyang, Wuhan, Nanjing, Shanghai
2026-01
Not yet open
A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients
NCT07338396Non Small Cell Lung Cancer NSCLC
Guangzhou University of Traditional Chinese Medicine
Observational
3,000
Beijing, Guangzhou, Weihui, Shanghai, Chengdu
2026-01
Not yet open
Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)
NCT07332494Coronary Heart Disease, Percutaneous Coronary Intervention
Beijing Anzhen Hospital
Not applicable
792
Beijing, Dalian, Jilin City
2026-01
Recruiting
A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
NCT07330934Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
403
Beijing
2025-12-31
Not yet open
Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
NCT07286695Metastatic Colorectal Cancer (CRC), Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
292
Beijing
2025-12-31
Active, closed
An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment
NCT06501976Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
9
Beijing
2025-12-31
Recruiting
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
NCT07318103Fluid Retention Caused by Heart Failure
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
153
Beijing
2025-12-31
Not yet open
Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC
NCT07242274NSCLC (Non-small Cell Lung Cancer)
Jemincare
Phase 3
472
Beijing
2025-12-31
Recruiting
A Study of B2065 in Patients With Acute Ischemic Stroke
NCT07371624Acute Ischemic Stroke
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
54
Beijing
2025-12-31
Not yet open
The Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD)
NCT07315399OSA - Obstructive Sleep Apnea, Coronary Microvascular Dysfunction (CMD), Coronary Artery Disease (CAD)
Beijing Anzhen Hospital
Observational
560
Beijing
2025-12-30
Not yet open
The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE
NCT07306585Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc.
Phase 1
32
Beijing
2025-12-30
Recruiting
Comparison of Cumulative Opioid Consumption Between Variable-Rate Feedback Infusion and Fixed-Rate Basal Infusion Modes of Intravenous PCA Following Mixed Surgery
NCT07361822Surgery, Pain Management, Opioid Consumption, Patient-controlled Analgesia
Beijing Tiantan Hospital
Not applicable
1,170
Beijing
2025-12-30
Recruiting
Comparison of the Efficacy and Safety of Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode of Intravenous PCA Following Mixed Surgery
NCT07375121Surgery, Pain Management, Opioid Consumption, Patient Controlled Analgesia
Beijing Tiantan Hospital
Not applicable
450
Beijing
2025-12-30
Not yet open
ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
NCT07320326TCE-RRMM
Peking University People's Hospital
Observational
159
Beijing
2025-12-30
Recruiting
A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke
NCT07419997Stroke
Xuanwu Hospital, Beijing
Observational
2,600
Beijing
2025-12-29
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
NCT07143045EGFR Mutant Advanced Non-small Cell Lung Cancer, Central Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.
Observational
800
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Foshan, Guangzhou, Meizhou
2025-12-29
Recruiting
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
NCT07297329Multiple Myeloma (MM)
Sinocelltech Ltd.
Phase 3
292
Beijing
2025-12-29
Recruiting
A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT07376642Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Suzhou Immunofoco Biotechnology Co., Ltd
Phase EARLY_PHASE1
30
Beijing, Zhengzhou, Hangzhou
2025-12-29
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer
NCT07218809Epithelial Ovarian Cancer
AstraZeneca
Phase 3
1,100
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-12-29
Recruiting
The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4
NCT07241169Stargardt
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase EARLY_PHASE1
9
Beijing, Guangzhou
2025-12-29
Recruiting
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07225569Hidradenitis Suppurativa
Sanofi
Phase 2
144
Beijing, Changsha, Shanghai, Wuhan
2025-12-29
Recruiting
GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma
NCT07138547Lymphoma
Chinese PLA General Hospital
Phase 1/2
40
Beijing
2025-12-26
Recruiting
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
NCT07266116Systemic Light Chain Amyloidosis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1/2
70
Beijing, Chongqing, Fuzhou, Guangzhou, Shenzhen, Guiyang, Baoding, Harbin
2025-12-26
Recruiting
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
NCT07172360Active Ankylosing Spondylitis
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
420
Beijing
2025-12-26
Recruiting
68Ga-BCMA PET/CT in Multiple Myeloma
NCT07319897Multiple Myeloma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Multiple Myeloma and Plasma Cell Neoplasm
Peking University First Hospital
Phase 2/3
300
Beijing, Shijiazhuang, Jilin City
2025-12-25
Recruiting
Prospective Randomized Controlled Clinical Study of Acupoint Application With Gutong Plaster in the Treatment of Moderate to Severe Cancer Pain
NCT07657390Cancer Pains
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
198
Beijing
2025-12-25
Recruiting
Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
NCT07043894Solid Tumors, Hematological Tumor, Children, Adolescent
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
50
Beijing
2025-12-25
Recruiting
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
NCT06658197Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect
Xuanwu Hospital, Beijing
Phase 3
850
Beijing
2025-12-25
Active, closed
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
NCT07285902Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
572
Beijing, Nanjing
2025-12-25
Not yet open
Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy
NCT07296614Diminished Ovarian Reserve (DOR), Infertility
Peking Union Medical College Hospital
Phase 3
320
Beijing
2025-12-25
Not yet open
Cardiovascular Surgery Early Prediction System for AKI :CARDS-AKI Registry
NCT07330453Cardiovascular Surgery
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
5,000
Beijing
2025-12-25
Recruiting
A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
NCT07464912Idiopathic Pulmonary Fibrosis (IPF)
Beijing Tide Pharmaceutical Co., Ltd
Phase 3
508
Beijing
2025-12-24
Recruiting
A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
NCT07235202Pancreatic Ductal Adenocarcinoma (PDAC)
Shenzhen Majory Biotechnology Co., Ltd.
Phase 1/2
45
Beijing, Guangzhou, Harbin, Changchun
2025-12-24
Recruiting
ฮฒ-alanine in the Treatment of Advanced Hepatocellular Carcinoma
NCT07317414Hepatocellular Carcinoma
Peking Union Medical College Hospital
Phase 2
158
Beijing, Nanjing, Xuzhou
2025-12-24
Recruiting
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
NCT07284134Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
560
Hefei, Beijing, Fuzhou, Lanzhou, Wuwei, Guangzhou, Meizhou, Shantou
2025-12-24
Active, closed
Extracellular Vesicles for the Treatment of Syringomyelia
NCT07295067Syringomyelia
Xuanwu Hospital, Beijing
Phase 1
18
Beijing
2025-12-23
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336Breast Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
800
Anyang, Beijing, Changchun, Changde, Changsha, Chengdu, Deyang, Fuzhou
2025-12-22
Recruiting
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
NCT07248956Hypopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 2
116
Harbin, Jinan, Beijing, Shanghai, Tianjin
2025-12-22
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
NCT07586826Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers, Ovarian Cancer
Peking University People's Hospital
Phase 2
220
Beijing
2025-12-22
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
NCT07586813Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gastrointestinal Neoplasms, Pancreatic Cancer
Peking University People's Hospital
Phase 2
220
Beijing
2025-12-22
Recruiting
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
NCT07570212Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
Peking University First Hospital
Not applicable
50
Beijing
2025-12-22
Not yet open
A Study on the Effectiveness of Preventive Extensive Release of the Rotator Interval and Joint Capsule to Reduce Postoperative Stiffness in Arthroscopic Rotator Cuff Repair
NCT07311616Supraspinatus Tear
Beijing Jishuitan Hospital
Not applicable
50
Beijing
2025-12-22
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC
Phase 3
800
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanjing, Shanghai, Tianjin
2025-12-19
Not yet open
A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit
NCT07273227ASD - Atrial Septal Defect
China National Center for Cardiovascular Diseases
Phase 4
300
Beijing
2025-12-19
Recruiting
A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07418736Chronic Obstructive Pulmonary Disease
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2
318
Beijing
2025-12-18
By invitation
Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors
NCT07656090Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
19
Beijing
2025-12-18
Recruiting
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT07285460Hemophilia
Sanofi
Phase 3
85
Beijing
2025-12-18
Active, closed
Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke
NCT07271082Acute Ischemic Stroke
Capital Medical University
Not applicable
208
Fuyang, Suzhou, Beijing, Zhoukou, Shihezi
2025-12-18
Recruiting
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT07298239Prostate Cancer Castration-resistant Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
15
Beijing
2025-12-18
Recruiting
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
NCT07314294Metastatic Colorectal Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 2
54
Beijing, Guangzhou
2025-12-18
Recruiting
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
NCT07242417Solid Cancer, GPC3 Positive Hepatocellular Carcinoma
Beijing GoBroad Hospital
Phase EARLY_PHASE1
30
Beijing
2025-12-18
Recruiting
PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy
NCT07443696Ischemic Cardiomyopathy, Heart Failure
Sinotau Pharmaceutical Group
Phase 2
40
Beijing, Tianjin
2025-12-18
Recruiting
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308Acute Ischemic Stroke
Capital Medical University
Phase 3
1,192
Anqing, Bozhou, Fuyang, Maโ€™anshan, Suzhou, Wuhu, Beijing, Fuzhou
2025-12-18
Recruiting
Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors
NCT07280832Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors
Shanghai JMT-Bio Inc.
Phase 1/2
500
Beijing
2025-12-17
By invitation
Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome
NCT07276568Small-for-size Syndrome
Zhi-Jun Zhu
Phase EARLY_PHASE1
12
Beijing
2025-12-17
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
NCT07185997Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer, Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing
ArriVent BioPharma, Inc.
Phase 3
480
Beijing, Xiamen, Foshan, Shantou, Shijiazhuang, Harbin, Luoyang, Xinxiang
2025-12-17
Recruiting
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
NCT07464132Tumor, Cardiovascular Diseases, Pulmonary Fibrosis, Rheumatic Immune Diseases Involving Large Blood Vessels
Peking Union Medical College Hospital
Phase 1/2
30
Beijing
2025-12-17
Recruiting
A Phase โ… /โ…กa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
NCT07228247Solid Tumors, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Guangzhou, Hefei, Shanghai, Shenyang, Zhengzhou
2025-12-16
Rows per page Showing 1201–1300 of 5484
Previous 11 12 13 14 15 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=13

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.